Reset

Advanced Filters
Wednesday
PCA800 - News from the CDC: STD Trends, CQI, New Tools and More! (Rx = .25 hr.)
08:00am - 08:45am Eastern - March 25, 2015 | Room: Forum Southwest
Track: Pre-Conference A
Credits Available: 0.25 Pharmacology  |  0.75 Physician  |  0.90 CA RN/CA BRN  |  0.75 RN/NP (All RNs/Nurses except CA RNs)  |  0.75 CNM  |  0.75 Physician Assistant  |  0.75 Other

Wednesday
PCA845 - HPV: New Frontiers in Prevention and Diagnosis (Rx = .5 hr.)
08:45am - 09:30am Eastern - March 25, 2015 | Room: Forum Southwest
Track: Pre-Conference A
Credits Available: 0.50 Pharmacology  |  0.75 Physician  |  0.90 CA RN/CA BRN  |  0.75 RN/NP (All RNs/Nurses except CA RNs)  |  0.75 CNM  |  0.75 Physician Assistant  |  0.75 Other
Learning Objectives:
  • Describe updated recommendations for the 9-valent HPV vaccine.
  • Discuss evidence-based ways to improve HPV vaccination rates.
  • Describe the potential implications of HPV vaccination on HPV-related cancer rates.

Wednesday
PCA930 - Genital Herpes: Common Conundrums and Sensible Solutions (Rx = .25 hr.)
09:30am - 10:15am Eastern - March 25, 2015 | Room: Forum Southwest
Track: Pre-Conference A
Credits Available: 0.25 Pharmacology  |  0.75 Physician  |  0.90 CA RN/CA BRN  |  0.75 RN/NP (All RNs/Nurses except CA RNs)  |  0.75 CNM  |  0.75 Physician Assistant  |  0.75 Other
Learning Objectives:
  • Identify typical and atypical clinical presentations of patients who have genital herpes.
  • Describe the risks of transmission and potential complications for individuals who have genital herpes.
  • List recommended treatment regimens, options for suppressive antiviral therapy, and possible future vaccine options forĀ individuals who have genital herpes.

Wednesday
PCA1030 - Improving Sexual Health for Women Having Sex with Women
10:30am - 11:15am Eastern - March 25, 2015 | Room: Forum Southwest
Track: Pre-Conference A
Credits Available: 0.00 Pharmacology  |  0.75 Physician  |  0.90 CA RN/CA BRN  |  0.75 RN/NP (All RNs/Nurses except CA RNs)  |  0.75 CNM  |  0.75 Physician Assistant  |  0.75 Other
Learning Objectives:
  • List appropriate questions to identify a patient's gender identity, sexual orientation, and sexual behavior.
  • Describe the epidemiology and risk factors for unintended pregnancy and STIs among WSW.
  • Describe relevant safer sex strategies and considerations regarding reproductive health screening for this population.

Wednesday
PCA1115 - Gonorrhea and Chlamydia: Update on Epidemiology, Testing and Treatment Issues - Q&D Faculty Panel (Rx = .25 hr.)
11:15am - 12:30pm Eastern - March 25, 2015 | Room: Forum Southwest
Track: Pre-Conference A
Credits Available: 0.25 Pharmacology  |  1.25 Physician  |  1.50 CA RN/CA BRN  |  1.25 RN/NP (All RNs/Nurses except CA RNs)  |  1.25 CNM  |  1.25 Physician Assistant  |  1.25 Other
Learning Objectives:
  • Discuss current trends in the epidemiology of chlamydia and gonorrhea.
  • Review tests available for the diagnosis of chlamydia and gonorrhea.
  • Discuss CDC recommended treatments for chlamydia and gonorrhea.

Wednesday
PCA145 - STD Treatment and Prevention for Two: Updates in Pregnancy and STDs (Rx = .25 hr.)
01:45pm - 02:30pm Eastern - March 25, 2015 | Room: Forum Southwest
Track: Pre-Conference A
Credits Available: 0.25 Pharmacology  |  0.75 Physician  |  0.90 CA RN/CA BRN  |  0.75 RN/NP (All RNs/Nurses except CA RNs)  |  0.75 CNM  |  0.75 Physician Assistant  |  0.75 Other
Learning Objectives:
  • Describe the epidemiology of sexually-transmitted infections in pregnancy.
  • Detail effective screening and diagnosis strategies for pregnant women.
  • Describe recommended treatment of STIs in pregnancy.

Wednesday
PCA230 - Skill Building and Clinical Pearls: Challenging Cases in STI Management (Rx = .5 hr.)
02:30pm - 03:30pm Eastern - March 25, 2015 | Room: Forum Southwest
Track: Pre-Conference A
Credits Available: 0.50 Pharmacology  |  1.00 Physician  |  1.20 CA RN/CA BRN  |  1.00 RN/NP (All RNs/Nurses except CA RNs)  |  1.00 CNM  |  1.00 Physician Assistant  |  1.00 Other
Learning Objectives:
Wednesday
PCA345 - "Safer" Sex? The Truth About Oral Sex and STIs - Q&D Faculty Panel (Rx = .25 hr.)
03:45pm - 05:00pm Eastern - March 25, 2015 | Room: Forum Southwest
Track: Pre-Conference A
Credits Available: 0.50 Pharmacology  |  1.25 Physician  |  1.50 CA RN/CA BRN  |  1.25 RN/NP (All RNs/Nurses except CA RNs)  |  1.25 CNM  |  1.25 Physician Assistant  |  1.25 Other
Learning Objectives:
  • Review data indicating oral sex behaviors have increased in the US population.
  • Provide examples (HSV1, HPV, and multi-drug resistant gonorrhea) of orally transmitted STIs.
  • Review oral STI screening recommendations.

Thursday
THU800 - Program Overview & Objectives/Non-Contraceptive Benefits of LARC (Rx = .25 hr.)
08:00am - 08:45am Eastern - March 26, 2015 | Room: Grand Ballroom
Track: Main Conference
Credits Available: 0.25 Pharmacology  |  0.75 Physician  |  0.90 CA RN/CA BRN  |  0.75 RN/NP (All RNs/Nurses except CA RNs)  |  0.75 CNM  |  0.75 Physician Assistant  |  0.75 Other
Learning Objectives:
  • Discuss noncontraceptive effects of the etonogestrel implant.
  • Review noncontraceptive effects of the 2 types of intrauterine contraception.
  • Apply knowledge of noncontraceptive benefits to contraceptive counseling.

Thursday
THU845 - Determinants of Contraceptive Failure (Rx =.25 hr.)
08:45am - 09:15am Eastern - March 26, 2015 | Room: Grand Ballroom
Track: Main Conference
Credits Available: 0.25 Pharmacology  |  0.50 Physician  |  0.60 CA RN/CA BRN  |  0.50 RN/NP (All RNs/Nurses except CA RNs)  |  0.50 CNM  |  0.50 Physician Assistant  |  0.50 Other
Learning Objectives:
  • Describe the difference between contraceptive failure during typical use and contraceptive failure during perfect use.
  • Describe the error in most estimates of contraceptive failure during perfect use.
  • Describe the reason for the increase in the Pearl index for FDA-approved OCs over time.